Parmax Pharma Ltd - 540359 - Board Meeting Intimation for Board Meeting Intimation For Unaudited Financial Results For Quarter Ended 31St Deccember, 2023.
Parmax Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 ,inter alia, to consider and approve Board Meeting intimation for unaudited financial results for quarter ended 31st Deccember, 2023. Parmax Pharma Ltd - 540359 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
Intimation for resignation of Company Secretary and Compliance officer. Parmax Pharma Ltd - 540359 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of SEBI (DP)Regulations 2018 for quarter ended 31st December, 2023 Parmax Pharma Ltd - 540359 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 And Amendments Thereto ('Listing Regulations').
Additional disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Parmax Pharma Ltd - 540359 - Intimation Of Fire Accident
Intimation of fire accident at plant Parmax Pharma Ltd - 540359 - Financial Results For Quarter And Half Year Ended 30.09.2023
Unaudited Financial results for quarter and half year ended 30.09.2023 Parmax Pharma Ltd - 540359 - Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of The Company
Outcome of the meeting of the Board of Directors of the Company Parmax Pharma Ltd - 540359 - Board Meeting Intimation for Intimation Of Board Meeting In Compliance With Reg. 29 Read With Reg. 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Parmax Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2023 ,inter alia, to consider and approve Intimation of Board Meeting in compliance with Reg. 29 read with Reg. 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Parmax Pharma Ltd - 540359 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance certificate under regulation 74(5) of SEBI (Depository Participants) Regulations 2018